High Incidence of Congenital Hypothyroidism in One Region of the Republic of Macedonia

Open access

Abstract

Congenital hypothyroidism (CH) is the most common preventable cause of mental retardation in children. Diagnosis is difficult at birth without neonatal screening. Neonatal thyroid screening was established in Prilep, Republic of Macedonia as an integral part of the nationwide screening program. To estimate the prevalence of CH in this region, neonatal thyroid screening was performed on 9757 newborns, during the period 2002-2011. The DELFIA method was applied to measure the thyroid-stimulating hormone (TSH) concentration in dried blood spot samples on standard filter paper taken 48 hours after birth by heel-stick. The TSH cut-off level was 10 mU/L.

The neonatal thyroid screening coverage was 93.4%. Eight newborns with CH were detected, with an incidence of 1:1220 live births, significantly higher compared to the nationwide results 1:2602. The TSH level was not significantly dependent on the gender of the newborn. There was a statistically significant difference between the TSH level and the timing of newborn screening sampling (p <0.05) and between the TSH level and the newborn birth weight (p = 0.01). One point ninety-two percent of newborns with TSH levels above 5 mU/L indicated an iodine sufficiency in Prilep. The incidence of CH in Prilep, which is higher when compared with that reported in surrounding countries, might be a consequence of the higher percentage of the Romany population in this region. Further analysis of this population in other regions is warranted.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. American Academy of Pediatrics Rose SR Section on Endocrinology and Committee on Genetics American Thyroid Association Brown RS Public Health Committee Lawson Wilkins Pediatric Endocrine Society Folley T Kaplowitz PB Kaye CL Sundararjan S Varma SK. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006; 117(6): 2290-2303.

  • 2. Anastasovska V Kocova M. Ten years experience with neonatal screening of congenital hypothyroidism in the Republic of Macedonia (abstract of the oral presentation). Proceedings of the 8th International Society for Neonatal Screening (INS) European Neonatal Screening Regional Meeting Budapest Hungary November 4-6 2012. Orvosi Hetilap O45: 26 ISNS 2012.

  • 3. Fellow GF LaFranchi SH. Screening for congenital hypothyroidism: A worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28(2):175-187.

  • 4. Samardžić M Gligorović-Barhanović N Popović N Popović-Samardžić M. Newborn screening program for congenital hypothyroidism in Montenegro. Paediatrics Today. 2013; 9(2): 158-162.

  • 5. Roberts HE Moore CA Fernhoff PM Brown AL Khoury MJ. Population study of congenital hypothyroidism and associated birth defects Atlanta 1979-1992. Am J Med Genet. 1997; 71(1): 29-32.

  • 6. Loeber JG. Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis. 2007; 30(4): 430-438.

  • 7. Panamonta O Tuksapun S Kiatchoosakam P Jirapradittha J Kirdpon W Loapaiboon M. Newborn screening for congenital hypothyroidism in Khon Kaen University Hospital the first three years a preliminary report. J Med Assoc Thai. 2003; 86(10): 932-937.

  • 8. Daher R Beaini M Mahfouz R Cortas N Younis KA. A neonatal screening in Lebanon: Results of five years’ experience. Ann Saudi Med. 2003; 23(1-2): 16-19.

  • 9. State Statistical Office Republic of Macedonia. Natality in the Republic of Macedonia by municipality 2011 (available at www.stat.gov.mk).

  • 10. Rastogi MV Lafranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010; 5:17. doi: 10.1186/ 1772-5-17 (review).

  • 11. Olney RS Grosse SD Vogt JR. Prevalence of congenital hypothyroidism - current trends and future directions: Workshop summary. Pediatrics. 2010; 125 (Suppl 2): S631-S36.

  • 12. Al-Maghamsi MS Al-Hawsawi ZM Ghulam GN Okasha AM. Screening for congenital hypothyroidism in north-west region of Saudi Arabia. Saudi Med J. 2002; 23(12): 1518-1521.

  • 13. Zeinalzadeh AH Talebi M. Neonatal screening for congenital hypothyroidism in East Azerbaijan Iran: The first report. J Med Screen. 2012; 19(3): 123-126.

  • 14. Abduljabbar MA Afifi AM. Congenital hypothyroidism. J Pediatr Endocrinol Metab. 2012; 25(1-2): 13-29.

  • 15. Simsek E Karabay M Kocabay K. Neonatal screening for congenital hypothyroidism in West Black Sea area Turkey. J Clin Pract. 2005; 59(3): 336-341.

  • 16. Mikelsaar RV Zordania R Viikmaa M Kudrjavtseva G. Neonatal screening for congenital hypothyroidism in Estonia. J Med Screen. 1998; 5(1): 20-21.

  • 17. Hashemipour M Amini M Iranpour R Sadri GH Javaheri N Haghighi S et al. Prevalence of congenital hypothyroidism in Isfahan Iran: Results of a survey on 20000 neonates. Horm Res. 2004; 62(1): 79-83.

  • 18. Karanfilski B Bogdanova V Vaskova O Loparska S Miceva S Sestakov G et al. Correction of iodine deficiency in Macedonia. J Pediatr Endocrinol Metab. 2003; 16(7):1041-1045.

  • 19. Dunn J. Macedonia is declared Iodine Sufficient. IDD Newslett. 2004; 20: 16-17.

  • 20. Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Horm Res. 1997; 48(2): 51-61.

  • 21. Delange F. Neonatal thyroid screening as a monitoring tool for the control of iodine deficiency. Acta Pae diatr. 1999; 88(432): 21-24.

  • 22. World Health Organization United Nations Children’s Fund International council for the control of iodine deficiency disorders. Indicators for assessing iodine deficiency disorders and their control through salt iodization. WHO/ NUT/94.6 edition. World Health Organization Geneva Switzerland 1994 (www.who.int).

  • 23. Burus R Mayne PD O’Herlihy C Smith DF Higgins M Staines A et al. Can neonatal TSH screening reflect trends in population iodine intake? Thyroid. 2008; 18(8): 883-888.

  • 24. Gruneiro-Papendieck L Chiesa A Mendez V Bengolea S Prieto L. Neonatal TSH levels as an index of iodine sufficiency: differences related to time of screening sampling and methodology. Horm Res. 2004; 62(6): 272-276.

  • 25. Vandevijvere S Annemans L van Oyen H Tafforeau J Moreno-Reyes R. Projected reduction in healthcare costs in Belgium after optimization of iodine intake: Impact on costs related to thyroid nodular disease. Thyroid. 2010; 20(11): 1301-1306.

  • 26. Copeland DL Sullivan KM Houston R May W Mendoza I Salamatullah Q et al. Comparison of neonatal thyroid-stimulating hormone levels and indicators of iodine deficiency in school children. Public Health Nutr. 2002; 5(1): 81-87.

  • 27. Gyurjyan RH Lugovska R Vevere P van der Haar F. Newborn thyrotropin screening confirms iodine deficiency in Latvia. Eur J Clin Nutr. 2006; 60(5): 688-690.

Search
Journal information
Impact Factor

IMPACT FACTOR 2018: 0.769
5-year IMPACT FACTOR: 0.892

CiteScore 2018: 0.66

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.372

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 176 80 1
PDF Downloads 79 41 1